» Articles » PMID: 15155221

Structure and Association of Human Lactoferrin Peptides with Escherichia Coli Lipopolysaccharide

Overview
Specialty Pharmacology
Date 2004 May 25
PMID 15155221
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

An 11-amino-acid amphipathic synthetic peptide homologous to a helical region on helix 1 of human lactoferrin HLP-2 exhibited bactericidal activity against Escherichia coli serotype O111, whereas an analogue synthesized with Pro substituted for Met, HLP-6, had greatly reduced antimicrobial activity. The bactericidal activity of HLP-2 was 10-fold greater than that of HLP-6 in both buffer and growth medium by time-kill assays. These assays also showed a pronounced lag phase that was both concentration and time dependent and that was far greater for HLP-2 than for HLP-6. Both peptides, however, were shown to be equally efficient in destabilizing the outer membrane when the hydrophobic probe 1-N-phenylnaphthylamine was used and to have the same lipopolysaccharide (LPS) binding affinity, as shown by polymyxin B displacement. Circular dichroism (CD) spectroscopy was used to study the structure and the organization of the peptides in solution and upon interaction with E. coli LPS. In the presence of LPS, HLP-2 and HLP-6 were found to bind and adopt a beta-strand conformation rather than an alpha-helix, as shown by nonimmobilized ligand interaction assay-CD spectroscopy. Furthermore, this assay was used to show that there is a time-dependent association of peptide that results in an ordered formation of peptide aggregates. The rate of interpeptide association was far greater in HLP-2 LPS than in HLP-6 LPS, which was consistent with the lag phase observed on the killing curves. These results allow us to propose a mechanism by which HLP-2 folds and self-assembles at the outer membrane surface before exerting its activity.

Citing Articles

Lactoferrins in Their Interactions with Molecular Targets: A Structure-Based Overview.

Piacentini R, Boffi A, Milanetti E Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543184 PMC: 10974892. DOI: 10.3390/ph17030398.


Synergistic bactericide and antibiotic effects of dimeric, tetrameric, or palindromic peptides containing the RWQWR motif against Gram-positive and Gram-negative strains.

Vargas-Casanova Y, Rodriguez-Mayor A, Cardenas K, Lucia Leal-Castro A, Munoz-Molina L, Fierro-Medina R RSC Adv. 2022; 9(13):7239-7245.

PMID: 35519960 PMC: 9061098. DOI: 10.1039/c9ra00708c.


The tetrameric peptide LfcinB (20-25) derived from bovine lactoferricin induces apoptosis in the MCF-7 breast cancer cell line.

Guerra J, Cardenas A, Ochoa-Zarzosa A, Meza J, Umana Perez A, Fierro-Medina R RSC Adv. 2022; 9(36):20497-20504.

PMID: 35515557 PMC: 9065741. DOI: 10.1039/c9ra04145a.


Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, and Other Lactoferrin-Derived Peptides.

Gruden S, Poklar Ulrih N Int J Mol Sci. 2021; 22(20).

PMID: 34681923 PMC: 8541349. DOI: 10.3390/ijms222011264.


Lactoferrin, Quercetin, and Hydroxyapatite Act Synergistically against .

Montone A, Papaianni M, Malvano F, Capuano F, Capparelli R, Albanese D Int J Mol Sci. 2021; 22(17).

PMID: 34502150 PMC: 8431635. DOI: 10.3390/ijms22179247.


References
1.
Chapple D, Mason D, Joannou C, Odell E, Gant V, Evans R . Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111. Infect Immun. 1998; 66(6):2434-40. PMC: 108221. DOI: 10.1128/IAI.66.6.2434-2440.1998. View

2.
Boman H . Peptide antibiotics and their role in innate immunity. Annu Rev Immunol. 1995; 13:61-92. DOI: 10.1146/annurev.iy.13.040195.000425. View

3.
Hancock R, LEHRER R . Cationic peptides: a new source of antibiotics. Trends Biotechnol. 1998; 16(2):82-8. DOI: 10.1016/s0167-7799(97)01156-6. View

4.
Kondejewski L, Farmer S, Hancock R, Kay C, Hodges R . Diastereoisomeric analogues of gramicidin S: structure, biologicalactivity and interaction with lipid bilayers. Biochem J. 2000; 349 Pt 3:747-55. PMC: 1221201. DOI: 10.1042/bj3490747. View

5.
Houston Jr M, Kondejewski L, Karunaratne D, Gough M, Fidai S, Hodges R . Influence of preformed alpha-helix and alpha-helix induction on the activity of cationic antimicrobial peptides. J Pept Res. 1998; 52(2):81-8. DOI: 10.1111/j.1399-3011.1998.tb01361.x. View